SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-196421
Filing Date
2013-05-02
Accepted
2013-05-02 17:12:13
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d503321d10q.htm 10-Q 514659
2 EX-10.4 d503321dex104.htm EX-10.4 5643
3 EX-10.5 d503321dex105.htm EX-10.5 15293
4 EX-10.6 d503321dex106.htm EX-10.6 38287
5 EX-10.7 d503321dex107.htm EX-10.7 198628
6 EX-31.1 d503321dex311.htm EX-31.1 7387
7 EX-31.2 d503321dex312.htm EX-31.2 7640
8 EX-32 d503321dex32.htm EX-32 6344
  Complete submission text file 0001193125-13-196421.txt   2767588

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ctic-20130331.xml EX-101.INS 214295
10 XBRL TAXONOMY EXTENSION SCHEMA ctic-20130331.xsd EX-101.SCH 25774
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20130331_cal.xml EX-101.CAL 44207
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20130331_def.xml EX-101.DEF 151742
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20130331_lab.xml EX-101.LAB 219345
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20130331_pre.xml EX-101.PRE 177197
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 13809196
SIC: 2834 Pharmaceutical Preparations